Presented at #ScientificSessions26:
In patients with type 2 diabetes and high cardiovascular risk, a systolic blood-pressure target below 120 mm Hg did not result in fewer major cardiovascular events than a target below 140 mm Hg. Full OPTIMAL-DIABETES trial results: https://t.co/8LPXfkfp2R
@AHAScience
it’s incredible that in the relentless march of progress forward in creating a healthier population, doctors have made so few mistakes that they can be summed up in a tweet
The prevalence of large language model-associated words rose substantially in the 2024 application cycle, while changes to linguistic complexity, personalization, and topic diversity were modest https://t.co/TfOZc684Gr #MedEd
Seen at least 5 patients in past three years as second opinion for unexplained polycythemia in CKD patients on #sglt2i
Two underwent bone marrow biopsy…
Some patients do have significantly pronounced erythropoiesis
@JAMA_current@ASNKidney
https://t.co/zKOf3qQg50
In a real world analysis of Non Randomized observational data, #Fineranone was associated with a reduction in events vs #spironolactone in the treatment of #HFpEF (hypothesis generating data)
https://t.co/Bny8AwjcmT
Apparent resistant hypertension affected about 40% of people with CKD and type 2 dm in CONFIDENCE. Finerenone plus empagliflozin lowered BP more than either drug alone, on par with spironolactone but without its hyperkalemia burden. Now in JACC: Advances: https://t.co/0Ubo3xpu8m
Please for heavens sake DON’T put your patients at risk. I recommend both Daratumumab based therapy and plasma exchange for acute light chain cast nephropathy specially in newly diagnosed myeloma.
These papers which mix up patients cause me more problems. Dara VCd plus plasma exchange is the best therapy for acute light chain cast nephropathy. If you treat patients with some other cause for renal failure with this approach it won’t help. If you have a doubt on the diagnosis of acute light chain cast nephropathy, renal biopsy will be needed.
If you start therapy late when the renal failure has been there for over a month therapy won’t work. If you give suboptimal therapy (Dara alone etc) you cannot hope for the plasma exchange to work. If you give Dara based therapy without plasma exchange you can’t hope for renal recovery quickly because it takes 2-4 weeks for the therapy to work and in that time the kidney is getting damaged. You need BOTH in a timely manner.
In 2012 I said machines would do 80% of what doctors do. Many were furious. Now AI out-diagnoses doctors in study after study. Is printing organs on demand next? Having your own stem cell repository is next generation "planning".
@cellinobio is building autonomous foundries that make personalized stem cells with AI and lasers. Your cells age every day. Preserve your immune cells with @withreservoir. Excited to back @nabihasaklayen, @madridmarinna & team.
Just published @TheLancet
Global threats to health in the 21st century
an opus, 59 page comprehensive dissection of all the threats we face
https://t.co/xr4oKEHujR @IHME_UW
No, they can't measure blood pressure accurately.
American Heart Statement: "currently available devices may be inappropriate for clinical use." and "using these devices to guide treatment could lead to inappropriate care and may pose safety risks to patients." @American_Heart
https://t.co/B66Me4YaTO open-access
gift link https://t.co/hFBPPv0cet
Based on solid evidence, all mammograms should include 3 AI algorithms and they should be free to patients: (1) better detection of breast cancer, (2) detecting cancer risk in the next 5 years despite a "normal" mammogram, and (3) risk of heart disease.
https://t.co/ead144H2XW
Todays' article on future risk (2)
https://t.co/WMtDZpuKyL